Chen, C., Gu, Y., Zhang, F., Zhang, Z., Zhang, Y., He, Y., . . . Li, Y. (2021). Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer. Oncoimmunology.
Chicago Style citaatChen, Cong, et al. "Construction of PD1/CD28 Chimeric-switch Receptor Enhances Anti-tumor Ability of C-Met CAR-T in Gastric Cancer." Oncoimmunology 2021.
MLA citatieChen, Cong, et al. "Construction of PD1/CD28 Chimeric-switch Receptor Enhances Anti-tumor Ability of C-Met CAR-T in Gastric Cancer." Oncoimmunology 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.